Bellerophon Therapeutics Stock Forecast
Bellerophon Therapeutics stock price ended at $0.0571 on Monday, after gaining 3.73%.
(Updated on Apr 15, 2024)
The Bellerophon Therapeutics stock price gained 3.73% on the last trading day (Monday, 15th Apr 2024), rising from $0.0550 to $0.0571. During the last trading day the stock fluctuated 6.64% from a day low at $0.0535 to a day high of $0.0571. The price has risen in 5 of the last 10 days and is up by 2.7% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 10 thousand shares were bought and sold for approximately $588.70 .
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.19% during the next 3 months and, with a 90% probability hold a price between $0.0427 and $0.0563 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
BLPH Signals & Forecast
The Bellerophon Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0561 and $0.0545. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 11, 2024, and so far it has risen 7.44%. Further rise is indicated until a new top pivot has been found. Bellerophon Therapeutics has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
A buy signal from a double bottom formation was found on Friday, March 15, 2024 with a target of $0.0520. Despite whether the objective of the signal formation has been reached the stock may continue to perform well.
Support, Risk & Stop-loss for Bellerophon Therapeutics stock
Bellerophon Therapeutics finds support from accumulated volume at $0.0550 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0036 between high and low, or 6.64%. For the last week, the stock has had daily average volatility of 7.90%.
Our recommended stop-loss: $0.0547 (-4.10%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 2 days ago.)
Trading Expectations (BLPH) For The Upcoming Trading Day Of Tuesday 16th
For the upcoming trading day on Tuesday, 16th we expect Bellerophon Therapeutics to open at $0.0559, and during the day (based on 14 day Average True Range), to move between $0.0514 and $0.0627, which gives a possible trading interval of +/-$0.0056 (+/-9.83%) up or down from last closing price. If Bellerophon Therapeutics takes out the full calculated possible swing range there will be an estimated 19.66% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.0573 (0.44%) than the support at $0.0550 (3.59%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Bellerophon Therapeutics stock A Buy?
Bellerophon Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: 0.700 Hold/Accumulate Unchanged
Predicted Opening Price for Bellerophon Therapeutics of Tuesday, April 16, 2024
| Fair opening price April 16, 2024 | Current price |
|---|---|
| $0.0559 ( 2.07%) | $0.0571 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BLPH
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.0594 | 4.15 % | |
| R2 | 0.0581 | 1.77 % | ||
| R1 | 0.0572 | 0.303 % | ||
| Current price: | 0.0571 | |||
| Support | S1 | 0.0545 | -4.45 % | |
| S2 | 0.0537 | -5.92 % | ||
| S3 | 0.0523 | -8.30 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.0640 | 12.18 % | |
| R2 | 0.0610 | 6.92 % | ||
| R1 | 0.0573 | 0.438 % | ||
| Current price | 0.0571 | |||
| Support | S1 | 0.0550 | -3.59% | |
| S2 | 0.0533 | -6.66% | ||
| S3 | 0.0510 | -10.60% |
FAQ
Click here for our free guide on how to buy Bellerophon Therapeutics Stock.
